MedPath

The Effect of Dexmedetomidine Analgesia and Sedation in Minimally Invasive Spine Surgery Under Local Anesthesia

Registration Number
NCT02535273
Lead Sponsor
Tang-Du Hospital
Brief Summary

Evaluate safety and efficacy of dexmedetomidine in minimally invasive spine surgery under local anesthesia sedation.Explore the appropriate concentration of dexmedetomidine, whether or not can reduce the amount of local anesthetics.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
212
Inclusion Criteria
  • Sign the informed consent;
  • American Society of Anesthesiologists (ASA)classification:class I~II;Elective minimally invasive spine surgery;
  • Age ≥18 years old, weighing 45 ~ 80 Kg, height 151 ~ 185 cm;
  • hypertension within Ⅱ grade, or controlled with drugs within Ⅱ level;
  • Diabetes fasting in 8.3mol/L or less
Exclusion Criteria
  • DEX allergy;
  • Change anesthesia preoperative or intraoperative ;
  • metabolic disorders, anemia has not been corrected;
  • recent patients receiving sedatives and antidepressants;
  • degenerative diseases of the central nervous elderly persons;
  • serious central nervous system diseases (acute stroke, uncontrolled epilepsy, severe dementia);
  • hypovolemia; 8) unstable angina or acute myocardial infarction;
  • left ventricular ejection fraction less than 30%, heart rate lower than 45bpm;
  • II-III degree heart block;
  • acute hepatitis or severe liver disease (liver function C level);
  • patients with renal insufficiency randomly assigned to receive treatment, but If patients need dialysis test is excluded or interruption ;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Low-dose DexmedetomidineDexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.3 μg/kg/min until the end of surgery
Low-dose DexmedetomidineLow-dose Dexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.3 μg/kg/min until the end of surgery
Moderate-dose DexmedetomidineDexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.5 μg/kg/min until the end of surgery
High-dose DexmedetomidineDexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.7 μg/kg/min until the end of surgery
High-dose DexmedetomidineHigh-dose Dexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.7 μg/kg/min until the end of surgery
normal saline Control groupnormal salineIntravenous injection normal saline equal quantity,completed within 10 minutes. Local anesthesia: lidocaine Intravenous infusion of normal saline 0.125 μg/kg/min until the end of surgery
Moderate-dose DexmedetomidineModerate-dose Dexmedetomidineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.5 μg/kg/min until the end of surgery
Low-dose DexmedetomidineLidocaineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.3 μg/kg/min until the end of surgery
Moderate-dose DexmedetomidineLidocaineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.5 μg/kg/min until the end of surgery
High-dose DexmedetomidineLidocaineload dosage:Intravenous injection dexmedetomidine 1 µg/kg,completed within 10 minutes. Local anesthesia: lidocaine maintenance dose:Intravenous infusion of dexmedetomidine 0.7 μg/kg/min until the end of surgery
normal saline Control groupLidocaineIntravenous injection normal saline equal quantity,completed within 10 minutes. Local anesthesia: lidocaine Intravenous infusion of normal saline 0.125 μg/kg/min until the end of surgery
Primary Outcome Measures
NameTimeMethod
Ramsay sedation scoreFrom 1min before dexmedetomidine infusion to 2h after surgery,up to 4 hours

Evaluation time point:1min before dexmedetomidine infusion;1min before local anesthesia;lidocaine infiltrate layer by layer to the periosteum,assessed up to 2min;Intraoperative most painful moments,assessed up to 5min;1min before returning to the ward;2h after surgery.Intraoperative most painful moments:nucleus pulpous probe or Balloon Dilatation.

visual analogue scaleFrom 1min before dexmedetomidine infusion to 2h after surgery,up to 4 hours

Evaluation time point:1min before dexmedetomidine infusion;1min before local anesthesia;lidocaine infiltrate layer by layer to the periosteum,assessed up to 2min;Intraoperative most painful moments,assessed up to 5min;1min before returning to the ward;2h after surgery.Intraoperative most painful moments:nucleus pulpous probe or Balloon Dilatation.

Secondary Outcome Measures
NameTimeMethod
The total amount of lidocaine2h after surgery;
The patient and the surgeon satisfaction2h after surgery;

four grades:Very satisfied; General satisfied; Not satisfied; Very dissatisfied

© Copyright 2025. All Rights Reserved by MedPath